| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Director | Common Stock | 1,621,118 | $45,448,205 | $28.04 | 15 Nov 2022 | By RiverVest Venture Fund IV, L.P. |
| Reneo Pharmaceuticals, Inc. | Director | Common Stock | 2,188,713 | $13,735,706 | $6.28 | 08 May 2023 | By RiverVest Venture Fund IV, L.P. |
| SPRUCE BIOSCIENCES, INC. | Director | Common Stock | 1,326,305 | $1,296,463 | $0.9775 | 16 Feb 2023 | By RiverVest Venture Fund IV, L.P. |
| SPRUCE BIOSCIENCES, INC. | Director | Common Stock Warrant (Right to Buy) | 472,800 | 16 Feb 2023 | By RiverVest Venture Fund IV, L.P. | ||
| SPRUCE BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 30,000 | 25 May 2023 | Direct | ||
| Reneo Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 17,500 | 06 Jun 2023 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 17,000 | 02 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:13 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 25 May 2023 | 1 | $0 | 4 | Director | 26 May 2023, 17:39 |
| OKUR | Reneo Pharmaceuticals, Inc. | 08 May 2023 | 1 | +$1,000,000 | 4 | Director | 10 May 2023, 17:47 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 16 Feb 2023 | 2 | +$1,998,368 | 4 | Director | 16 May 2023, 16:08 |
| MIRM | Mirum Pharmaceuticals, Inc. | 11 Nov 2022 | 3 | -$5,956,855 | 4 | Director | 15 Nov 2022, 19:02 |
| MIRM | Mirum Pharmaceuticals, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 17:55 |
| OKUR | Reneo Pharmaceuticals, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 17:00 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 25 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:16 |
| MIRM | Mirum Pharmaceuticals, Inc. | 04 Jun 2021 | 1 | $0 | 4 | Director | 08 Jun 2021, 16:38 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 20 May 2021 | 1 | $0 | 4 | Director | 21 May 2021, 21:09 |